BioNexus Gene Lab (BGLC) EBIT (2018 - 2026)
BioNexus Gene Lab's (BGLC) quarterly EBIT came in at -$282396.0 in Q2 2026, up 53.8% year-over-year from -$183608.3 in Q2 2025, and up 47.75% quarter-over-quarter from -$540490.0 in Q1 2026.
Powered by 
Analysis
BioNexus Gene Lab (BGLC) EBIT (2018 - 2026) Analysis & Trends
BioNexus Gene Lab has disclosed EBIT across 9 years of filings, most recently posting -$282396.0 for Q2 2026.
- In Q2 2026, EBIT rose 53.8% year-over-year to -$282396.0; the TTM figure through Jun 2026 stood at -$2.6 million (up 14.26% YoY), while the FY2025 annual figure was -$3.0 million, down 88.41% from the prior year.
- EBIT came in at -$282396.0 for Q2 2026 at BioNexus Gene Lab, up from -$540490.0 in the prior quarter.
- In the past five years, EBIT ranged from a high of $259168.0 in Q2 2024 to a low of -$2.5 million in Q3 2023.
- Average EBIT over 5 years is -$458134.3, with a median of -$277297.5 recorded in 2023.
- The largest YoY upside for EBIT was 310.09% in 2023 against a maximum downside of 3777.19% in 2023.
- Over 5 years, EBIT stood at -$122689.0 in 2022, then jumped by 310.09% to $257754.0 in 2023, then plunged by 261.48% to -$416220.0 in 2024, then slumped by 148.15% to -$1.0 million in 2025, then surged by 72.66% to -$282396.0 in 2026.
- Per Business Quant data, the three most recent EBIT figures were -$282396.0 in Q2 2026, -$540490.0 in Q1 2026, and -$1.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | W.W. Grainger | 60.39 Bn | 59.80 Bn | 1.98 Bn | 807.00 Mn |
| 2 | Fastenal | 56.00 Bn | 55.79 Bn | 1.06 Bn | 501.80 Mn |
| 3 | Ferguson Enterprises | 43.40 Bn | 42.58 Bn | 2.32 Bn | 612.00 Mn |
| 4 | Reliance | 20.18 Bn | 19.94 Bn | 1.30 Bn | 441.60 Mn |
| 5 | Wesco International | 17.41 Bn | 16.60 Bn | 1.46 Bn | 382.20 Mn |
| 6 | Applied Industrial Technologies | 12.13 Bn | 12.00 Bn | 411.22 Mn | 159.31 Mn |
| 7 | Watsco | 11.83 Bn | 11.37 Bn | 578.93 Mn | 238.37 Mn |
| 8 | Avantor | 10.07 Bn | 9.76 Bn | 537.00 Mn | 121.80 Mn |
| 9 | Core & Main | 7.85 Bn | 7.70 Bn | 520.00 Mn | 177.00 Mn |
| 10 | BioNexus Gene Lab | 2.69 Mn | -829,345.91 | 12,982.00 | -282,396.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -282,396.00 |
| Mar 31, 2026 | -540,490.00 |
| Dec 31, 2025 | -1.03 Mn |
| Sep 30, 2025 | -702,509.00 |
| Jun 30, 2025 | -611,293.00 |
| Mar 31, 2025 | -618,418.00 |
| Dec 31, 2024 | -416,220.00 |
| Sep 30, 2024 | -1.34 Mn |
| Jun 30, 2024 | 259,168.00 |
| Mar 31, 2024 | -79,028.00 |
| Dec 31, 2023 | 257,754.00 |
| Sep 30, 2023 | -2.53 Mn |
| Jun 30, 2023 | -272,199.00 |
| Mar 31, 2023 | -50,631.00 |
| Dec 31, 2022 | -122,689.00 |
| Sep 30, 2022 | -65,215.00 |
| Jun 30, 2022 | -137,964.00 |
| Mar 31, 2022 | 34,691.00 |
| Dec 31, 2021 | 201,063.00 |
| Sep 30, 2021 | 372,641.00 |